BackAdicet Bio Overview

Adicet Bio Net Tangible Assets

Latest net tangible assets for ACET: $100M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$102.70M
↓ 5.91% YoYΔ $-6.45M vs prior year quarter

Peer trimmed avg / median

Loading

Adicet Bio Net Tangible Assets History

Loading

Adicet Bio vs. peers: Net Tangible Assets Comparison

Loading

Adicet Bio Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Adicet Bio (ACET) FAQ

Adicet Bio (ACET) currently reports a net tangible assets of $100M as of September 2026. That compares with $110M in the prior-year period — down 5.9% year over year. Use the charts on this page to explore Adicet Bio's net tangible assets history and peer comparisons.

Adicet Bio's net tangible assets decreased from $110M to $100M — a 5.9% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Adicet Bio reported $100M in net tangible assets as of September 2026. That compares with $110M in the prior-year period — down 5.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $100M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Adicet Bio, and consider following ACET for alerts when major investors trade the stock.

Adicet Bio is classified in the Healthcare sector. On net tangible assets, it currently shows $100M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACET with unrelated industries.